Dashboard
Financial statements
BAX

Company financials

Baxter International

Health Care Health Care Equipment Deerfield, Illinois Last filing Feb 12, 2026 · FY2025
Revenue FY2025
$11.2B
3y CAGR +3.8% P43
Net income FY2025
$-957.0M
Net margin -8.5% P6
Total assets FY2025
$20.1B
ROA -4.8% P7
Operating cash flow FY2025
$845.0M
FCF margin +3.0% P14
19 yrs · FY2007–FY2025 9 filed · 0 derived · 0 blank

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

29 accounts · 3 years
Total assets $20.1B
Total liabilities $14.0B
Shareholders equity $6.1B
Account 2025 2024 2023 Trend
Assets
Cash and Cash Equivalents 17.5% 16.6% 29.7%
Accounts Receivable 16.6% 15.8% 16.6%
Inventory 19.9% 19.2% 18.5%
Prepaid Expenses 7.2% 7.1% 6.8%
Other Current Assets 0.0% 24.5% 21.0%
Total Current Assets 61.1% 83.2% 92.7%
Property,Plant and Equipment 25.9% 27.0% 27.7%
Operating Lease Assets 2.5% 2.9% 3.2%
Goodwill 43.8% 49.6% 55.9%
Intangible Assets 38.9% 49.1% 57.1%
Other Noncurrent Assets 6.2% 30.6% 36.3%
Total Assets 178.4% 242.4% 272.9%
Liabilities
Accounts Payable 8.9% 9.1% 8.5%
Accrued Liabilities 17.5% 17.5% 18.5%
Current Portion of Long Term Debt 0.0% 25.9% 25.7%
Other Current Liabilities 0.0% 8.7% 10.0%
Total Current Liabilities 26.4% 61.2% 62.8%
Long Term Debt 84.2% 97.5% 107.0%
Operating Lease Liabilities Noncurrent 2.0% 2.3% 2.6%
Other Noncurrent Liabilities 11.4% 15.3% 18.8%
Total Liabilities 124.1% 176.4% 191.2%
Equity
Common Stock 6.1% 6.4% 6.6%
Additional Paid In Capital 56.6% 60.4% 61.7%
Retained Earnings 121.9% 140.4% 155.5%
Treasury Stock 96.7% 104.0% 108.4%
Accumulated Other Comprehensive Income -33.4% -37.7% -34.3%
Total Stockholders Equity 54.5% 65.5% 81.1%
Noncontrolling Interest -0.2% 0.6% 0.6%
Total Liabilitiesand Equity 178.4% 242.4% 272.9%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 3 years
Ratio 2025 2024 2023
Profitability
Gross margin +30.1% +37.5% +40.1%
Operating margin -2.7% +0.1% +6.8%
Net margin -8.5% -6.1% +25.6%
FCF margin +3.0% +5.4% +12.5%
Growth
Revenue CAGR (3y) +3.8% -4.3% -3.9%
Returns
ROE -15.6% -9.3% +31.6%
ROA -4.8% -2.5% +9.4%
ROIC -2.3% +0.1% +2.8%
Liquidity
Current ratio 2.31x 1.36x 1.48x
Quick ratio 1.29x 0.53x 0.74x
Leverage
D/E 2.28x 2.69x 2.36x
Interest coverage -1.29x 0.04x 1.61x
Efficiency
Asset turnover 0.56x 0.41x 0.37x
Cash conversion cycle +118d +117d +122d

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched
Saving notes adds BAX to your watchlist.